ClinicalTrials.gg
Drug

Lacosamide clinical trials

Also written Vimpat and SPM 927.

studies test it
91
open now
5
in phase 3
42
first study started
2001

How each study uses Lacosamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lacosamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Oct 2008 · VIMPAT · NDA 022253 (FDA, Drugs@FDA)
European Union
29 Aug 2008 · Vimpat · EMEA/H/C/000863 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lacosamide
60
LCM
8
Lacosamide tablet
4
Harkoseride
4
SPM927/Lacosamide
3

Brand

Vimpat
50

Development codes

SPM 927
16
ADD 234037
1

Other names

Erlosamide
1

Studies by the year they started

91 studies that test it; most in 2004 (10)

Studies that test Lacosamide, by start year
YearStudies
20013
20023
20031
200410
20051
20062
20073
20084
20093
20108
20116
20126
20134
20148
20154
20162
20174
20182
20193
20201
20211
20224
20234
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
13
Phase 2
26
Phase 3
42
Phase 4
11
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 59 · Other 32

UCB Pharma (32) · UCB BIOSCIENCES, Inc. (12) · UCB Biopharma S.P.R.L. (4) · Kafrelsheikh University (3) · UCB Pharma SA (3) · UCB BIOSCIENCES GmbH (3) · UCB Biopharma SRL (2) · Le Bonheur Children's Hospital (2)

Often tested with

Tested in the same studies.

Levetiracetam (7) · Phenobarbital (3) · Pregabalin (2) · Topiramate (2) · Valproic Acid (2) · Propranolol (1) · Fosphenytoin (1) · Phenytoin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test Lacosamide, phase 3 first.

Studies

Open first, then newest update. How each study uses Lacosamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 91

See all 91 studies that test Lacosamide →

Given beside what is tested · 1 — Lacosamide is usual care or a partner of the new treatment

Codes

What other systems call Lacosamide · ClinicalTrials.gg INT006830

  • MeSH (NLM) D000078334LacosamideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 563KS2PQY5LACOSAMIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 623400Confirmed FDA, Wikidata
  • Wikidata Q420077lacosamideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C83859LacosamideOne source FDA
  • DrugBank DB06218One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.